Stocks and InvestingStocks and Investing
Wed, April 14, 2021
Tue, April 13, 2021
Mon, April 12, 2021
Fri, April 9, 2021

Anita Dushyanth Initiated (BTAI) at Strong Buy and Held Target at $75 on, Apr 9th, 2021


Published on 2024-10-27 16:10:53 - WOPRAI, Anita Dushyanth
  Print publication without navigation


Anita Dushyanth of Berenberg, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $75 on, Apr 9th, 2021.

Anita has made no other calls on BTAI in the last 4 months.



There are 4 other peers that have a rating on BTAI. Out of the 4 peers that are also analyzing BTAI, 0 agree with Anita's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Anita


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $175 on, Thursday, April 1st, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $127 on, Thursday, April 1st, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $95 on, Thursday, April 1st, 2021
  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $99 on, Monday, February 1st, 2021